BEAT BioTherapeutics Corp

Biotechnology company · Bellevue, Washington, United States

BEAT BioTherapeutics Corp is a biotechnology company headquartered in Bellevue, Washington, United States. Its earliest recorded incorporation is in 2008. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $1.5 million in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $2.4 million sold in a notice filed in 2013.

Profile compiled from public records. Is this your company? Request a correction or update

BEAT BioTherapeutics at a glance

Typebiotechnology company
HeadquartersBellevue, Washington, United States
Earliest incorporation on record2008
Employees (self-reported, 2016)1
SEC CIK1574133

What does BEAT BioTherapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $1.5 million in total (2016). NIH funding came from the National Heart, Lung, and Blood Institute.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $2.4 million sold (2013).

Frequently asked questions about BEAT BioTherapeutics

Where is BEAT BioTherapeutics headquartered?

BEAT BioTherapeutics Corp is headquartered in Bellevue, Washington, United States.

What does BEAT BioTherapeutics do?

BEAT BioTherapeutics Corp is a biotechnology company.

When was BEAT BioTherapeutics founded?

The earliest incorporation on record for BEAT BioTherapeutics Corp is in 2008, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences